Zenghui Teng

994 citations
30 papers · 737 indexed · h-index 17
Topics
Nanoparticle-Based Drug Delivery (6 papers)Nanoplatforms for cancer theranostics (5 papers)Immunotherapy and Immune Responses (4 papers)

In The Last Decade

Zenghui Teng

30 papers receiving 731 citations

Peers

Zenghui Teng
Comparison fields: 5 of 95
  • Molecular Biology 343
  • Plant Science 101
  • Biomaterials 97
  • Oncology 91
  • Biomedical Engineering 90
Replace Meng‐Lei Huan with:
Meng‐Lei Huan China
Artur Beberok Poland
Da Yeon Lee South Korea
Joanna Jakubowicz-Gil Poland
Anees Rahman Pakistan
Aline Pinon France
Siraj Pallichankandy United Arab Emirates
Mika Reinisalo Finland
Chaomei Liu United States
Ayşegül Varol Germany
Zenghui Teng relative to Meng‐Lei Huan China Meng‐Lei Huan's profile →
Citations per field
00.5×1.7×
Meng‐Lei Huan · 1×
Citations per year

Countries citing papers authored by Zenghui Teng

Since Specialization
Citations

This map shows the geographic impact of Zenghui Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zenghui Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zenghui Teng more than expected).

Fields of papers citing papers by Zenghui Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zenghui Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zenghui Teng. The network helps show where Zenghui Teng may publish in the future.

Co-authorship network of co-authors of Zenghui Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Zenghui Teng. A scholar is included among the top collaborators of Zenghui Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zenghui Teng. Zenghui Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 38
3 16
4 18
5 23
6 6
7 15
8 18
9 11
10 117
11 21
12 19
13 60
14 25
15 75
16 18
17 34
18 28
19 12
20
[Biliary excretion of genistein and its metabolite at different doses in rats].
1

About Zenghui Teng

Zenghui Teng is a scholar working on Biophysics, Geriatrics and Gerontology and Biomaterials, having authored 30 papers that have together received 737 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Geriatrics and Gerontology (36 citations), Biochemistry (49 citations) and Pharmacology (69 citations). Zenghui Teng has collaborated with scholars based in China, Germany and United Kingdom. Frequent co-authors include Qibing Mei, Siyuan Zhou, Meng‐Lei Huan, Bang‐Le Zhang, Jingyue Yang, Da‐Yong Cao, Weidong Cao, Han Cui, Feng Zhang and Rong Zhang. Their work appears in journals such as PLoS ONE, The Journal of Physiology and Journal of Agricultural and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026